Compass Therapeutics, Inc.
Balance Sheet
| Line Item | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | Dec 2020 | Sep 2020 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $26.2M | $136.4M | $144.5M | $25.5M | $31.2M | $39.7M | $47.1M | $55.5M |
| Accounts Receivable | — | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $134.5M | $140.3M | $147.1M | $28.6M | $34.5M | $41.6M | $50.2M | $57.8M |
| Property, Plant & Equipment | $1.9M | $2.1M | $2.2M | $1.4M | $1.2M | $1.2M | $1.1M | $2.4M |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $140.3M | $146.6M | $153.8M | $34.9M | $40.9M | $48.2M | $51.9M | $60.7M |
| Liabilities | ||||||||
| Accounts Payable | $6.5M | $257.0K | $867.0K | $868.0K | $559.0K | $1.1M | $1.1M | $854.0K |
| Total Current Liabilities | $10.9M | $9.3M | $10.6M | $7.7M | $8.4M | $10.9M | $10.1M | $9.7M |
| Long-Term Debt | — | — | $0 | $0 | $0 | — | $1.9M | $3.7M |
| Total Liabilities | $13.3M | $12.1M | $13.7M | $11.0M | $12.0M | $14.7M | $12.0M | $13.4M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-249.2M | $-240.8M | $-233.6M | $-220.6M | $-214.6M | $-158.8M | $-151.4M | $-143.0M |
| Total Stockholders' Equity | $126.9M | $134.5M | $140.1M | $23.9M | $28.9M | $33.5M | $39.9M | $47.3M |